The novel 5-HT4 receptor antagonist DAU 6285 antagonizes 5-hydroxytryptamine-induced tachycardia in pigs
- 23 March 1993
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 233 (2-3) , 295-297
- https://doi.org/10.1016/0014-2999(93)90065-p
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The 5-HT4 receptor: a place in the sunTrends in Pharmacological Sciences, 1992
- DAU 6285: A novel antagonist at the putative 5-HT4 receptorLife Sciences, 1992
- Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1992
- 5-Hydroxytryptamine: a chameleon in the heartTrends in Pharmacological Sciences, 1991
- Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pigBritish Journal of Pharmacology, 1991
- Mediation of 5‐hydroxytryptamine‐induced tachycardia in the pig by the putative 5‐HT4 receptorBritish Journal of Pharmacology, 1990
- Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptorsBritish Journal of Pharmacology, 1988
- 5‐Hydroxytryptamine‐induced tachycardia in the pig: possible involvement of a new type of 5‐hydroxytryptamine receptorBritish Journal of Pharmacology, 1988